ESR1 promoter methylation in breast cancer and AR promoter methylation in prostate cancer are two examples of events that are known to contribute to the pathogenesis and prognosis of the corresponding tumour types34, 35, 36. This evidence concerns the gene ESR1 and breast carcinoma.